别名 EIF2AK3、eukaryotic translation initiation factor 2 alpha kinase 3、Eukaryotic translation initiation factor 2-alpha kinase 3 + [5] |
简介 Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to various stress conditions. Key activator of the integrated stress response (ISR) required for adaptation to various stress, such as unfolded protein response (UPR) and low amino acid availability (By similarity). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed:33384352). Serves as a critical effector of unfolded protein response (UPR)-induced G1 growth arrest due to the loss of cyclin-D1 (CCND1). Involved in control of mitochondrial morphology and function (By similarity). |
靶点 |
作用机制 PERK抑制剂 |
在研机构 Hibercell, Inc.初创企业 |
原研机构 Hibercell, Inc.初创企业 |
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点 |
作用机制 PERK抑制剂 |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2024-10-16 |
申办/合作机构- |
开始日期2022-09-09 |
开始日期2021-06-08 |
申办/合作机构 Hibercell, Inc.初创企业 [+1] |